A team of engineers, computer scientists and ophthalmologists at the University of California, Berkeley, working with a pair of colleagues at the University of Washington, has developed a ...

A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

In celebration of Ophthalmology Times' 50th anniversary, we asked leading experts in the field what they see as the biggest innovation in ophthalmology in the past 5 decades. In celebration of ...

Background/aims Sebaceous carcinoma (SC ... Conclusions One-half of the patients with eyelid SC with nodal metastasis had negative findings at initial presentation but developed nodal metastasis ...

Background/aims There is a paucity in the literature on the presentation, management and outcomes of cases where primary acquired melanosis (PAM) is associated with spill over/contiguous periocular ...

Microsoft PowerPoint Mobile is the best app for reviewing, delivering, and creating presentations on Windows phones and tablets (with a screen size of 10.1 inches or ...

The support and advocacy from the American Academy of Ophthalmology (AAO ... more children who need it-regardless of their financial background. It's a major step forward for both patients ...

Their leadership has been instrumental in shaping a path forward for broader adoption of digital therapies in pediatric ophthalmology ... This dichoptic presentation encourages the visual system ...

Smetana, MD, professor of medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, in a presentation ... a standardized triple-pill background therapy.